EDS Formulations Suppress Breast Cancer in Pre-Trial Testing
Baltimore, MD., September 28, 201b /PRNewswire/ — Epigenetic Data Sciences’ (EDS) new pre-trial results could pave the way for gene targeted treatment options for the estimated 1.7 million women worldwide who are...